Literature DB >> 21920560

Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage.

Mithu Storoni1, Sean J Pittock, Brian G Weinshenker, Gordon T Plant.   

Abstract

PURPOSE: To investigate the presence of an ethnicity bias within patients presenting with optic neuritis in London.
DESIGN: Observational cross-sectional study.
METHODS: The ethnicity profile of all patients attending a neuro-ophthalmology clinic in central London with acute optic neuritis over a 16month period (n=86) was studied. A comparison was made with the ethnicity profile of the population of London as well as patients with Multiple Sclerosis-associated optic neuritis (n=41), Neuromyelitis Optica spectrum disorder-associated optic neuritis (n=27) and patients with an atypical corticosteroid-dependent optic neuropathy (21).
RESULTS: The ethnicity profile of the patient cohort presenting to our clinic with acute optic neuritis over a 16 month period closely matched the ethnicity profile of London (P=0.08). Within this cohort, patients of African or African-Caribbean heritage were found to be more likely to manifest either a pattern or aetiology of optic neuritis requiring immunosuppressive treatment in comparison with patients of a white Caucasian background (relative risk 3.47; 95% CI=1.092 to 11.007). There was a disproportionately high representation of patients from an African or African-Caribbean background within the Neuromyelitis Optica spectrum-related optic neuritis diagnostic group (P<0.00).
CONCLUSIONS: Patients with acute isolated optic neuritis from African or African Caribbean backgrounds are over 3 times more likely than patients of white Caucasian backgrounds to have an 'atypical' pattern of optic neuritis where corticosteroid therapy may be required. Our results suggest that a patient's ethnic background is an important factor to be taken into consideration when deciding on the diagnosis and management of acute isolated optic neuritis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920560      PMCID: PMC3912859          DOI: 10.1016/j.jns.2011.08.030

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  21 in total

1.  Optic neuritis in African Americans.

Authors:  P H Phillips; N J Newman; M J Lynn
Journal:  Arch Neurol       Date:  1998-02

2.  The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.

Authors: 
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

3.  Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population.

Authors:  R Deschamps; L Paturel; S Jeannin; N Chausson; S Olindo; O Béra; R Bellance; D Smadja; D Césaire; P Cabre
Journal:  Mult Scler       Date:  2010-09-22       Impact factor: 6.312

4.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

5.  Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.

Authors:  Masahiko Nakamura; Toru Nakazawa; Hiroshi Doi; Takehiro Hariya; Kazuko Omodaka; Tatsuro Misu; Toshiyuki Takahashi; Kazuo Fujihara; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-19       Impact factor: 3.117

6.  Autoimmune optic neuropathy: evaluation and treatment.

Authors:  M J Kupersmith; R M Burde; F A Warren; T G Klingele; L P Frohman; H Mitnick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

7.  Chronic relapsing inflammatory optic neuropathy (CRION).

Authors:  D Kidd; B Burton; G T Plant; E M Graham
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

8.  Multiple sclerosis in black children.

Authors:  N Zelnik; A D Gale; S A Shelburne
Journal:  J Child Neurol       Date:  1991-01       Impact factor: 1.987

9.  Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.

Authors:  Patrick Waters; Sven Jarius; Edward Littleton; Maria Isabel Leite; Saiju Jacob; Bryony Gray; Ruth Geraldes; Thomas Vale; Anu Jacob; Jacqueline Palace; Susan Maxwell; David Beeson; Angela Vincent
Journal:  Arch Neurol       Date:  2008-07

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  10 in total

Review 1.  Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported.

Authors:  Axel Petzold; Gordon T Plant
Journal:  J Neurol       Date:  2013-05-23       Impact factor: 4.849

Review 2.  Update on neuromyelitis optica: natural history and management.

Authors:  Panitha Jindahra; T Plant
Journal:  Eye Brain       Date:  2012-03-26

3.  Retinal damage and vision loss in African American multiple sclerosis patients.

Authors:  Dorlan J Kimbrough; Elias S Sotirchos; James A Wilson; Omar Al-Louzi; Amy Conger; Darrel Conger; Teresa C Frohman; Shiv Saidha; Ari J Green; Elliot M Frohman; Laura J Balcer; Peter A Calabresi
Journal:  Ann Neurol       Date:  2015-01-13       Impact factor: 10.422

4.  Etiologies of Acute Optic Neuritis in Thailand: An Observational Study of 171 Patients.

Authors:  Kavin Vanikieti; Pavarut Janyaprasert; Sirin Lueangram; Jirat Nimworaphan; Natthapon Rattanathamsakul; Nanida Tiraset; Wimonwan Chokthaweesak; Narong Samipak; Tanyatuth Padungkiatsagul; Pisit Preechawat; Anuchit Poonyathalang; Teeratorn Pulkes; Supoch Tunlayadechanont; Sukanya Siriyotha; Panitha Jindahra
Journal:  Clin Ophthalmol       Date:  2020-09-30

5.  Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial.

Authors:  Heather E Moss; Weihua Gao; Laura J Balcer; Charlotte E Joslin
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

6.  Predictors of recurrence following an initial episode of transverse myelitis.

Authors:  Dorlan J Kimbrough; Maureen A Mealy; Alexandra Simpson; Michael Levy
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-04-24

7.  Clinical Profile and Outcomes of Optic Neuritis in an HIV Prevalent Urban Community in South Africa.

Authors:  Hamzah Mustak; Colin Cook
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Jul-Sep

8.  Cases of neuromyelitis optica spectrum disorder from the East Africa region, highlighting challenges in diagnostics and healthcare access.

Authors:  Dilraj Sokhi; Adil Suleiman; Soraiya Manji; Juzar Hooker; Peter Mativo
Journal:  eNeurologicalSci       Date:  2021-01-23

9.  Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.

Authors:  Justin B McKee; John Elston; Nikos Evangelou; Stephen Gerry; Lars Fugger; Christopher Kennard; Yazhuo Kong; Jacqueline Palace; Matthew Craner
Journal:  BMJ Open       Date:  2015-11-09       Impact factor: 2.692

10.  Optic neuritis: Observation and experience at a tertiary care hospital in Qassim region, Saudi Arabia.

Authors:  Mohammad Jawad Alamgir; Syed Abrar Ali; Nermin Aly Hamdy; Moin Zafar Khan; Elgamri E Mohammad
Journal:  Int J Health Sci (Qassim)       Date:  2017 Nov-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.